The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2026

Filed:

Oct. 30, 2020
Applicant:

Astrazeneca Ab, Södertälje, SE;

Inventors:

Hannah Dry, Waltham, MA (US);

Brandon Willis, Waltham, MA (US);

Andrew Bloecher, Waltham, MA (US);

Jerome Mettetal, Waltham, MA (US);

Assignee:

AstraZeneca AB, Södertälje, SE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4985 (2013.01); A61K 31/519 (2013.01);
Abstract

The present disclosure relates to therapeutic combinations of acalabrutinib and capivasertib, or pharmaceutically acceptable salts thereof, for treating, preventing, partially alleviating, or ameliorating a B-cell malignancy, such as non-Hodgkin's lymphoma, in a subject in need thereof. The present disclosure also relates to pharmaceutical compositions comprising acalabrutinib and capivasertib. The present disclosure also relates to kits comprising acalabrutinib and capivasertib.


Find Patent Forward Citations

Dry, Hannah. (2026). Therapeutic combinations of acalabrutinib and capivasertib to treat b-cell malignancies (U.S. Patent No. 12691113). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12691113

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…